-
1 Comment
EDAP TMS S.A is currently in a long term downtrend where the price is trading 5.0% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.8.
EDAP TMS S.A's total revenue rose by 418.6% to $42M since the same quarter in the previous year.
Its net income has dropped by 33.4% to $-2M since the same quarter in the previous year.
Finally, its free cash flow fell by 37.8% to $3M since the same quarter in the previous year.
Based on the above factors, EDAP TMS S.A gets an overall score of 2/5.
Sector | Healthcare |
---|---|
Industry | Medical Distribution |
Exchange | NASDAQ |
CurrencyCode | USD |
ISIN | US2683111072 |
Market Cap | 70M |
---|---|
PE Ratio | None |
Target Price | 5.75 |
Beta | 0.13 |
Dividend Yield | None |
EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL segment manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters. This segment also sells spare parts and disposables, such as electrodes. The DIST segment markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing and sales channels, as well as through third-party distributors and agents. The company serves academic, public, and private hospitals as well as urology clinics. EDAP TMS S.A. was incorporated in 1979 and is based in Vaulx-en-Velin, France.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EDAP using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025